Accessibility Menu
 
Revolution Medicines logo

Revolution Medicines

(NASDAQ) RVMD

Current Price$144.04
Market Cap$30.08B
Since IPO (2020)+386%
5 Year+334%
1 Year+257%
1 Month+48%

Revolution Medicines Financials at a Glance

Market Cap

$30.08B

Revenue (TTM)

$0.00

Net Income (TTM)

$1.13B

EPS (TTM)

$-5.92

P/E Ratio

-24.36

Dividend

$0.00

Beta (Volatility)

1.31 (Average)

Price

$144.04

Volume

101,175

Open

$143.06

Previous Close

$144.04

Daily Range

$138.88 - $144.13

52-Week Range

$34.00 - $155.70

RVMD: Motley Fool Moneyball Superscore

69

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Revolution Medicines

Industry

Biotechnology

Employees

883

CEO

Mark A. Goldsmith, MD, PhD

Headquarters

Redwood City, CA 94063, US

RVMD Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-58%

Return on Capital

-57%

Return on Assets

-48%

Earnings Yield

-4.11%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$30.08B

Shares Outstanding

208.74M

Volume

101.17K

Avg. Volume

2.86M

Financials (TTM)

Gross Profit

$16.56M

Operating Income

$1.18B

EBITDA

$1.09B

Operating Cash Flow

$897.74M

Capital Expenditure

$15.99M

Free Cash Flow

$913.73M

Cash & ST Invst.

$2.03B

Total Debt

$158.70M

Revolution Medicines Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$4.70M

N/A

Gross Margin

0.00%

N/A

Market Cap

$30.08B

N/A

Market Cap/Employee

$48.84M

N/A

Employees

616

N/A

Net Income

$364.89M

-87.5%

EBITDA

$348.25M

-63.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$1.87B

-13.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$142.23M

+15.7%

Short Term Debt

$16.47M

+27.9%

Return on Assets

-48.05%

N/A

Return on Invested Capital

-57.28%

N/A

Free Cash Flow

$276.16M

-97.9%

Operating Cash Flow

$274.24M

-98.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ROIVRoivant Sciences Ltd.
$28.53+3.67%
MRNAModerna, Inc.
$45.94+0.48%
SMMTSummit Therapeutics Inc.
$21.46+3.02%
ASNDAscendis Pharma A/S
$229.38+4.13%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$12.91+0.04%
AMZNAmazon
$265.06+0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.63+0.10%
MARAMara Holdings
$11.99+0.12%

Questions About RVMD

What is the current price of Revolution Medicines?

Revolution Medicines is trading at $144.04 per share.

What is the 52-week range for Revolution Medicines?

Over the past 52 weeks, Revolution Medicines has traded between $34.00 and $155.70.

How much debt does Revolution Medicines have?

As of the most recent reporting period, Revolution Medicines reported total debt of $427.15M.

How much cash does Revolution Medicines have on hand?

Revolution Medicines reported $383.75M in cash and cash equivalents in its most recent financial results.

What is Revolution Medicines’s dividend yield?

Revolution Medicines does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.